Detail akcie Zentiva Bucurest online

Business Summary: Zentiva SA is a Romania-based company engaged in the pharmaceutical industry. The Company is primarily engaged in the production and commercialization of pharmaceutical preparations. The Company’s portfolio includes approximately 280 products and drugs for cardiovascular, nervous and digestive systems; pain treatment, and urological and anti-inflammatory diseases, among others. Additionally, the Company is active in the production of dietary supplements and vitamins. It has production sites in Czech Republic, Slovakia, Romania and Turkey. As of December 31, 2011, Venoma Holdings Limited held a 50.98% stake in Zentiva SA. The Company had one wholly owned subsidiary, Pallady Business Park SRL, as of December 31, 2011.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Zentiva SA revenues increased 24% to RON945.7M. Net income increased 92% to RON191.1M. Revenues reflect Revenue from sales of goods increase of 26% to RON886.1M, Rendering of services increase of 8% to RON59.6M. Net income benefited from Reversal of/ (expenses with) provisions decrease from RON3.2M (expense) to RON1.1M (income).